skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 next page
Refined by: author/creator: Vrablik, Michal remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics
Material Type:
Article
Add to My Research

Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics

Frontiers in genetics, 2022-03, Vol.13, p.849267-849267 [Peer Reviewed Journal]

Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. ;Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. 2022 Altschmiedova, Todorovova, Vrablik, and Ceska ;ISSN: 1664-8021 ;EISSN: 1664-8021 ;DOI: 10.3389/fgene.2022.849267 ;PMID: 35368707

Full text available

2
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
Material Type:
Article
Add to My Research

Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

Progress in cardiovascular diseases, 2023-07, Vol.79, p.2 [Peer Reviewed Journal]

ISSN: 1873-1740 ;DOI: 10.1016/j.pcad.2023.03.001

Digital Resources/Online E-Resources

3
The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion
Material Type:
Article
Add to My Research

The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion

Atherosclerosis. Supplements, 2019-12, Vol.39, p.e1

EISSN: 1878-5050 ;DOI: 10.1016/j.atherosclerosissup.2019.08.023 ;PMID: 31451336

Digital Resources/Online E-Resources

4
Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study
Material Type:
Article
Add to My Research

Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study

Frontiers in cardiovascular medicine, 2023-06, Vol.10, p.1206551-1206551 [Peer Reviewed Journal]

2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. ;2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. 2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella ;ISSN: 2297-055X ;EISSN: 2297-055X ;DOI: 10.3389/fcvm.2023.1206551 ;PMID: 37404744

Full text available

5
The Role of Nutraceuticals in Statin Intolerant Patients
Material Type:
Article
Add to My Research

The Role of Nutraceuticals in Statin Intolerant Patients

Journal of the American College of Cardiology, 2018-07, Vol.72 (1), p.96-118 [Peer Reviewed Journal]

2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 3, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.04.040 ;PMID: 29957236

Full text available

6
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
Material Type:
Article
Add to My Research

Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) http://creativecommons.org/licenses/by-nc-nd/4.0 ;ISSN: 0033-0620 ;EISSN: 1532-8643 ;DOI: 10.1016/j.pcad.2023.03.001 ;DOI: 10.5167/uzh-257579

Digital Resources/Online E-Resources

7
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins
Material Type:
Article
Add to My Research

A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins

Journal of cardiovascular pharmacology and therapeutics, 2022-01, Vol.27, p.10742484221138284

The Author(s) 2022 ;ISSN: 1074-2484 ;EISSN: 1940-4034 ;DOI: 10.1177/10742484221138284 ;PMID: 36420979

Full text available

8
Analysis of incidence and prevalence of cardiovascular risk factors and evaluation of their control in epidemiological survey in the Czech Republic
Material Type:
Article
Add to My Research

Analysis of incidence and prevalence of cardiovascular risk factors and evaluation of their control in epidemiological survey in the Czech Republic

Central European journal of public health, 2020-06, Vol.28 (2), p.114-119 [Peer Reviewed Journal]

Copyright National Institute of Public Health Jun 2020 ;ISSN: 1210-7778 ;EISSN: 1803-1048 ;DOI: 10.21101/cejph.a5730

Full text available

9
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
Material Type:
Article
Add to My Research

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Current atherosclerosis reports, 2021-10, Vol.23 (10), p.57 [Peer Reviewed Journal]

The Author(s) 2021 ;2021. The Author(s). ;ISSN: 1523-3804 ;EISSN: 1534-6242 ;DOI: 10.1007/s11883-021-00955-y ;PMID: 34345932

Digital Resources/Online E-Resources

10
Coronary heart disease and hormone replacement therapy - from primary and secondary prevention to the window of opportunity
Material Type:
Article
Add to My Research

Coronary heart disease and hormone replacement therapy - from primary and secondary prevention to the window of opportunity

Neuro-endocrinology letters, 2012, Vol.33 Suppl 2, p.17-21 [Peer Reviewed Journal]

ISSN: 0172-780X ;PMID: 23183504

Full text available

11
Oral but not transdermal estrogen replacement therapy reduced level of tissue factor pathway inhibitor: cross-over designed study
Material Type:
Article
Add to My Research

Oral but not transdermal estrogen replacement therapy reduced level of tissue factor pathway inhibitor: cross-over designed study

Neuro-endocrinology letters, 2006-10, Vol.27 (5), p.665-668 [Peer Reviewed Journal]

ISSN: 0172-780X ;PMID: 17159824

Full text available

12
Changes in Hemostatic Variables Induced by Estrogen Replacement Therapy: Comparison of Transdermal and Oral Administration in a Crossover-Designed Study
Material Type:
Article
Add to My Research

Changes in Hemostatic Variables Induced by Estrogen Replacement Therapy: Comparison of Transdermal and Oral Administration in a Crossover-Designed Study

Gynecologic and obstetric investigation, 2008-01, Vol.65 (1), p.47-51 [Peer Reviewed Journal]

2008 S. Karger AG, Basel ;2008 INIST-CNRS ;(c) 2008 S. Karger AG, Basel ;ISSN: 0378-7346 ;EISSN: 1423-002X ;DOI: 10.1159/000107492 ;PMID: 17713346 ;CODEN: GOBIDS

Full text available

13
Safety Evaluation of [alpha]-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies
Material Type:
Article
Add to My Research

Safety Evaluation of [alpha]-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies

Antioxidants, 2020-10, Vol.9 (10) [Peer Reviewed Journal]

COPYRIGHT 2020 MDPI AG ;ISSN: 2076-3921 ;EISSN: 2076-3921 ;DOI: 10.3390/antiox9101011

Full text available

14
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Material Type:
Article
Add to My Research

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

Cardiovascular diabetology, 2019-06, Vol.18 (1), p.71, Article 71 [Peer Reviewed Journal]

The Author(s) 2019 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-019-0864-7 ;PMID: 31164165

Full text available

15
Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech population
Material Type:
Article
Add to My Research

Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech population

European journal of internal medicine, 2015-06, Vol.26 (5), p.367 [Peer Reviewed Journal]

EISSN: 1879-0828 ;DOI: 10.1016/j.ejim.2015.02.019 ;PMID: 25753936

Digital Resources/Online E-Resources

16
Impact of apolipoprotein A5 variants on statin treatment efficacy
Material Type:
Article
Add to My Research

Impact of apolipoprotein A5 variants on statin treatment efficacy

Pharmacogenomics, 2009-06, Vol.10 (6), p.945-950 [Peer Reviewed Journal]

2009 © Future Medicine Ltd ;ISSN: 1462-2416 ;EISSN: 1744-8042 ;DOI: 10.2217/pgs.09.17 ;PMID: 19530961

Full text available

17
COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population
Material Type:
Article
Add to My Research

COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population

Drug metabolism and drug interactions, 2017-12, Vol.32 (4), p.177 [Peer Reviewed Journal]

Copyright Walter de Gruyter GmbH 2017 ;ISSN: 0792-5077 ;EISSN: 2191-0162 ;DOI: 10.1515/dmpt-2017-0027

Full text available

18
The Gene Score for Predicting Hypertriglyceridemia: New Insights from a Czech Case–Control Study
Material Type:
Article
Add to My Research

The Gene Score for Predicting Hypertriglyceridemia: New Insights from a Czech Case–Control Study

Molecular diagnosis & therapy, 2019-08, Vol.23 (4), p.555-562

Springer Nature Switzerland AG 2019 ;Copyright Springer Nature B.V. Aug 2019 ;ISSN: 1177-1062 ;EISSN: 1179-2000 ;DOI: 10.1007/s40291-019-00412-2 ;PMID: 31222479

Full text available

19
Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events
Material Type:
Article
Add to My Research

Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events

Drug metabolism and drug interactions, 2011-05, Vol.26 (1), p.13-20

ISSN: 0792-5077 ;EISSN: 2191-0162 ;DOI: 10.1515/dmdi.2011.107 ;PMID: 21557673

Full text available

20
Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol
Material Type:
Article
Add to My Research

Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol

Journal of clinical lipidology, 2013-05, Vol.7 (3), p.194 [Peer Reviewed Journal]

Copyright © 2013 National Lipid Association. Published by Elsevier Inc. All rights reserved. ;ISSN: 1933-2874 ;EISSN: 1876-4789 ;DOI: 10.1016/j.jacl.2013.02.003 ;PMID: 23725918

Digital Resources/Online E-Resources

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2009  (5)
  2. 2009 To 2011  (6)
  3. 2012 To 2015  (5)
  4. 2016 To 2019  (9)
  5. After 2019  (23)
  6. More options open sub menu

Resource Type 

  1. Articles  (47)
  2. Books  (2)
  3. More options open sub menu

Language 

  1. Japanese  (5)
  2. Spanish  (1)
  3. More options open sub menu

Suggested New Searches

Ignore my query and look for everything

by this author/creator:

  1. Vrablik, Michal
  2. Vrablik, Michal

Searching Remote Databases, Please Wait